examined the use of this reaction in the construction of
drug-like macrocycles. We report herein a novel and effi-
cient methodology to synthesize drug-like 5-iodo-1,2,3-
triazole-containing macrocycles through the implementa-
tion of copper-catalyzed cycloaddition chemistry in flow,
together with examples of the elaboration of these systems
via palladium-catalyzed cross-coupling reactions.
Table 1. Optimization of Reaction Conditionsa
We were drawn to a flow methodology employing
copper tubing because the copper(I)-catalyzed azideÀ
acetylene cycloaddition (CuAAC) reaction9 has already
been reported using flow conditions to yield simple, linear
triazoles.10 It was anticipated that using 1-iodoalkynes
instead of terminal alkynes would lead to similarly high
yields for the cycloaddition, using the heterogeneous cop-
per tube as the catalyst source.
Macrocycle precursors were synthesized in short syn-
thetic sequences similar to Scheme 1. Chiral amino alcohol
fragments were coupled to an organic azide using standard
peptide coupling conditions, followed by an alkylation
using propargyl bromide. The alkyne was subsequently
iodinated using N-iodomorpholine hydrogeniodide11 and
time
T
DIPEA
equiv
1cc
1c
entry
(min)
(°C)
ligand
(%)
(%)
1
2
3
4
5
6
7
5
5
75
100
100
100
100
100
100
TTTA (0.1)b
TTTA (0.1)
TTTA (0.1)
TTTA (0.5)
TTTA (0.1)
TBTA (0.1)
TTTA (0.1)
À
77
42
16
50
4
4
39
À
5
1.0
1.0
2.0
2.0
2.0
64
5
32
5
78
5
6
73
10
0
86
(80)d
30
8
9
5
5
100
100
À
À
À
52
27
2.0
51
a Conditions: Accendo Conjure Flow Reactor, copper tubing (0.75 mm
inner diamter, 1.6 mL internal volume), [1c] = 0.017 M. b Number in
parentheses corresponds to equivalents of ligand. c Percent UV from LC/
MS analysis. d Number in parentheses corresponds to isolated yield. TTTA,
tris-((1-tert-butyl-1H-1,2,3-triazoyl)methyl)amine; TBTA, tris-((1-benzyl-
1H-1,2,3-triazoyl)methyl)amine; DIPEA, diisopropylethylamine.
Scheme 1. Synthesis of Azido-Iodoalkyne Macrocycle Precur-
sors
tubing as the copper source.12 The conditions for the
macrocyclization are outlined in Table 1. Optimization
was performed using MeCN after initial screening indi-
cated promising results. Furthermore, its low boiling point
simplifies the workup, allowing convenient solvent re-
moval in vacuo prior to column chromatography. As anti-
cipated from our previous macrocyclization studies5 and
the seminal publication from Hein et al.,8 the ligand tris-
((1-tert-butyl-1H-1,2,3-triazoyl)methyl)amine (TTTA) was
necessary to obtain high yields of macrocycle 1 (Table 1,
entry 9 versus 5). It was also noted that addition of DIPEA
to the reaction mixture increased the yield of 1 (Table 1,
entries 3 and 5 versus entry 2). Increasing the temperature
beyond 100 °C resulted in decomposition of the starting
material and blocked the reactor. Optimal conditions for
the macrocyclization were determined to be 10 min at
100 °C, with 10 mol % TTTA and 2.0 equiv of DIPEA
(Table 1, entry 7). 5-Iodo-1,2,3-triazole-containing macro-
cycle 1was characterized by X-ray crystallography (Figure 1).
Additionally, it was determined that the reaction did not
proceed to high yield when no additives were present
(Table 1, entry 8) or when DIPEA was used alone
(Table 1, entry 9).
catalytic CuI. Notably, no CuAAC-derived macrocyclic or
oligomeric products were detected by LC/MS analysis
during the alkyne iodination, despite the presence of
copper(I). Following column chromatography, azido-io-
doalkyne 1c could be isolated as a light-yellow oil.
Using azido-iodoalkyne 1c as the model system, the
macrocyclization was optimized in flow, using copper
(9) (a) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem. 2001,
113, 2056–2075. Angew. Chem., Int. Ed. 2001, 40, 2004–2021.
(b) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.
Angew. Chem. 2002, 114, 2708–2711. Angew. Chem., Int. Ed. 2002, 41,
2596–2599. (c) Wu, P.; Fokin, V. V. Aldrichimica Acta 2007, 40, 7–17.
(d) Diez-Gonzalez, S. Catal. Sci. Technol. 2011, 1, 166. (e) Pedersen,
D. S.; Abell, A. Eur. J. Org. Chem. 2011, 2399. Hein, J. E.; Fokin, V. V.
Chem. Soc. Rev. 2010, 39, 1302.
(10) (a) Bogdan, A. R.; Sach, N. W. Adv. Synth. Catal. 2009, 351,
849–854. (b) Fuchs, M.; Goessler, W.; Pilger, C.; Kappe, C. O. Adv.
Synth. Catal. 2010, 352, 323–328. (c) Baxendale, I. R.; Ley, S. V.;
Mansfield, A. C.; Smith, C. D. Angew. Chem. 2009, 121, 4077–4081.
Angew. Chem., Int. Ed. 2009, 48, 4017–4021. (d) Smith, C. D.; Baxendale,
I. R.; Tranmer, G. K.; Baumann, M.; Smith, S. C.; Lewthwaite, R. A.;
Ley, S. V. Org. Biomol. Chem. 2007, 5, 1562–1568. (e) Smith, C. D.;
Baxendale, I. R.; Lanners, S.; Hayward, J. J.; Smith, S. C.; Ley, S. V. Org.
Biomol. Chem. 2007, 5, 1559–1561.
In order to establish the scope of this procedure, a series
of azido-iodoalkynes were synthesized and subjected to the
optimized macrocyclization conditions described above.
It was observed that macrocycles comprised of 12- to
(12) For the flow reactions, an Accendo Conjure Flow reactor was
used with copper tubing (0.75 mm inner diamter, 1.6 mL internal
(11) Koyama, M.; Ohtani, N.; Kai, F.; Moriguchi, I.; Inouye, S.
J. Med. Chem. 1987, 30, 552–562.
Org. Lett., Vol. 13, No. 15, 2011
4061